Literature DB >> 13678405

A specific mechanism of nonspecific inhibition.

Susan L McGovern1, Brian T Helfand, Brian Feng, Brian K Shoichet.   

Abstract

Promiscuous small molecules plague screening libraries and hit lists. Previous work has found that several nonspecific compounds form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes. It is not understood how aggregates inhibit their targets. To address this question, biophysical, kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins. By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact. This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates concentrate green fluorescent protein. beta-Lactamase mutants with increased or decreased thermodynamic stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compound, suggesting that denaturation by unfolding was not the primary mechanism of interaction. Instead, visualization by electron microscopy revealed that enzyme associates with the surface of inhibitor aggregates. This association could be reversed or prevented by the addition of Triton X-100. These observations suggest that the aggregates formed by promiscuous compounds reversibly sequester enzyme, resulting in apparent inhibition. They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678405     DOI: 10.1021/jm030266r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  187 in total

1.  Soft docking and multiple receptor conformations in virtual screening.

Authors:  Anna Maria Ferrari; Binqing Q Wei; Luca Costantino; Brian K Shoichet
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

2.  Compound library development guided by protein structure similarity clustering and natural product structure.

Authors:  Marcus A Koch; Lars-Oliver Wittenberg; Sudipta Basu; Duraiswamy A Jeyaraj; Eleni Gourzoulidou; Kerstin Reinecke; Alex Odermatt; Herbert Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

3.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

4.  Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB.

Authors:  Katherine A Rawls; Christoph Grundner; Jonathan A Ellman
Journal:  Org Biomol Chem       Date:  2010-07-19       Impact factor: 3.876

Review 5.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.

Authors:  Xuewen Du; Jie Zhou; Junfeng Shi; Bing Xu
Journal:  Chem Rev       Date:  2015-12-08       Impact factor: 60.622

6.  Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening.

Authors:  Yi Wen; Lei Xu; Fang-lei Chen; Jing Gao; Jing-ya Li; Li-hong Hu; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

7.  Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation.

Authors:  Julie A Zorn; Holger Wille; Dennis W Wolan; James A Wells
Journal:  J Am Chem Soc       Date:  2011-11-17       Impact factor: 15.419

8.  ALARM NMR for HTS triage and chemical probe validation.

Authors:  Jayme L Dahlin; Matthew Cuellar; Gurpreet Singh; Kathryn M Nelson; Jessica Strasser; Todd Rappe; Youlin Xia; Gianluigi Veglia; Michael A Walters
Journal:  Curr Protoc Chem Biol       Date:  2018-04-09

9.  Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).

Authors:  Peter C Gareiss; Krzysztof Sobczak; Brian R McNaughton; Prakash B Palde; Charles A Thornton; Benjamin L Miller
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

10.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

Authors:  Ajit Jadhav; Rafaela S Ferreira; Carleen Klumpp; Bryan T Mott; Christopher P Austin; James Inglese; Craig J Thomas; David J Maloney; Brian K Shoichet; Anton Simeonov
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.